ClinicalTrials.gg
CompletedNCT04897256Updated Nov 6, 2026Results posted

Mobility in Daily Life and Falls in Parkinson's Disease: Potential for Rehabilitation

An interventional study of TURN-IT exercise program in Parkinson Disease, sponsored by Oregon Health and Science University. Completed at 1 site in United States. Open to participants aged 55 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Oregon Health and Science University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 6, 2026Now CompletedResults posted+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
55
Allocation
Randomized
Ages
55 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 36 studies in Parkinson Disease by Oregon Health and Science University — 4 open to participants now, 4 under way, none of them phase 3. Parkinson Disease · Oregon Health and Science University.

Enrollment
10th of 28
55 · median 22
Started
2021
the only one that year
No phase
17 of 36
4 open now
Registered
32nd of 36
by date

Among the 36 studies in Parkinson Disease by Oregon Health and Science University, this one is the 10th largest by enrollment of the 28 interventional ones that give a count, is the only one that started in 2021, is one of 17 with no phase, and was the 32nd registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

4 of the 36 studies in Parkinson Disease by Oregon Health and Science University are open now, in 2 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 55 Years to 85 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 36 studies in Parkinson Disease by Oregon Health and Science University, or all of them as a file.
02

Study summary

The goal of this intervention is to explore the effectiveness of a Turning Intervention (TURN-IT) to improve quality of turning in participants with Parkinson's Disease (PD). An unique exercise program has been developed - TURN-IT - in which participants practice exercises that focus on physiological constraints that impair turning ability, such as axial rigidity, narrow base of support, bradykinesia, and inflexible set-shifting. The 60 participants with PD and a history of falls in the previous 12 months, will be randomized into a 6-week, 3x/week, one-on-one TURN-IT group or No-Intervention Control group. This pilot intervention study will determine the number of subjects needed for a future clinical trial and will determine the sensitivity to change with rehabilitation our daily-life turning quality measures (such as, mean and variability of number of steps to turn, turn amplitude, turn velocity). The investigators predict that the TURN-IT program will improve turning in daily life enough to justify a larger clinical trial.

03

Conditions studied

  • Parkinson Disease

Browse trials for

04

Who can participate

The criteria were revised on the registry on Nov 6, 2026. See what changed

Ages eligible
55 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Diagnosis of idiopathic PD from movement disorders neurologist with the United Kingdom Brain Bank criteria of bradykinesia with 1 or more of the following - rest tremor, rigidity, and balance problems not from visual, vestibular, cerebellar or proprioceptive conditions
  2. Responsive to levodopa
  3. Hoehn \& Yahr stages II-IV
  4. Age range 55-85 years old
  5. self-report of one or more falls in past 12 months
  6. willing and able to attend exercise intervention sessions at Oregon Health \& Science University (OHSU) campus, and also refrain from changes in anti-parkinson medications and exercise levels.

Exclusion criteria

Exclusion Criteria:

  1. Major musculoskeletal or neurological disorders, structural brain disease, epilepsy, acute illness or health history, other than PD
  2. no medical condition that precludes exercise
  3. (MoCA) ≤ 21 or inability to follow directions
  4. excessive use of alcohol or recreational drugs
  5. recent change in medication
  6. inability to stand and walk for 2 minutes without an assistive device
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
55 participants (actual)

Study arms

  • Experimental
    TURN-IT group

    Participants in the treatment group will attend supervised, 1-hour classes, 3 times per week for 6 weeks, one-on-one with the same exercise trainer, overseen by a physical therapist investigator.

    Behavioral: TURN-IT exercise program

  • No intervention
    No Intervention Control Group

    Participants in this group will be tested at baseline and 6 weeks later. They will go about their normal daily life during the 6 week period.

Interventions

  • BehavioralTURN-IT exercise program

    Based on the exercise motor learning principles, participants spend 10-15 minutes at each Exercise Station that focuses on particular constraints of turning ability. The stations will focus on important underlying aspects of turning, such as weight-shifting and increasing axial rotation during functional turning tasks. Each station will be progressed across levels to make more challenging (such as adding a dual task). Initially participants will be supported in an overhead body-weight support system (ZeroG) to allow them to practice challenging exercises without the risk of falling.

06

What researchers measure

Primary outcomes

  1. Variability in Number of Steps to Complete a Turn

    The coefficient of variation in the number of steps in a turn, averaged from daily monitoring, as measured at 6 weeks.

    Time frame: 6 weeks

Secondary outcomes

  1. Change in Falls Efficacy Scale International

    The difference in the Falls Efficacy Scale, as measured at baseline and 6 weeks. The Falls Efficacy Scale is a 16 item self-administered questionnaire to assess fear of falling. Scores range 16-64 with higher score indicating more fear of falling.

    Time frame: baseline and 6 weeks

  2. Prospective Fall Incidence

    Number of prospective falls recorded for 12 months starting from the end of intervention

    Time frame: 52 weeks

  3. Patient Global Impression of Change

    Question of participant's rating of mobility. Score range from 1-7 with 1-3 indicating improvement, 4 no change, and 5-7 worsening of mobility. Single score provided at the end of 6 week period.

    Time frame: 6 weeks

  4. Number of Steps to Complete a Turn

    The number of steps in a turning averaged from daily monitoring, as measured at 6 weeks.

    Time frame: 6 weeks

  5. Turn Peak Velocity

    Peak velocity of turns averaged from daily monitoring, as measured at 6 weeks.

    Time frame: 6 weeks

  6. Turn Angle Amplitude

    The peak size of turn angles averaged from daily monitoring, as measured at 6 weeks.

    Time frame: 6 weeks

  7. Turn Duration

    Time to complete turns averaged from daily monitoring, as measured at 6 weeks.

    Time frame: 6 weeks

  8. Variability of Double-support Time

    The coefficient of variation in time of double-support phase, as measured at 6 weeks.

    Time frame: 6 weeks

  9. Lateral Trunk Range

    The range of motion in the trunk during walking, in the lateral direction, as measured at 6 weeks.

    Time frame: 6 weeks

Other outcomes

  1. Change in Mini-Balance Evaluation Systems Test

    The change in mini-Balance Evaluation Systems Test, a clinical measure of four balance domains-anticipatory, reactive, sensory, and dynamic gait, as measured at baseline and 6 weeks. Scores range from 0-28 with higher scores indicating worse balance.

    Time frame: baseline and 6 weeks

  2. Clinical Global Impression of Change

    Question of clinician's rating of participant mobility. Score range from 1-7 with 1-3 indicating improvement, 4 no change, and 5-7 worsening of mobility. Single score provided at the end of 6 week period.

    Time frame: 6 weeks

  3. Change in Parkinson's Disease Questionnaire-39

    The difference in the Parkinson's disease questionnaire-39 (PDQ-39) - a 39 item self-report questionnaire to assess Parkinson's disease specific health related quality in eight domains of quality of life - as measured at baseline and 6 weeks. Each item scores from 0 (never) to 4 (always). Sub-scale scores and a Parkinson's Disease summary index (PDSI; sum of eight subsections/8) representing the global health-related quality of life will be calculated, with higher scores representing worse quality of life

    Time frame: baseline and 6 weeks

  4. Change in Unified Parkinson's Disease Rating Scale, Part III

    Difference in the Unified Parkinson's Disease Rating Scale, Part III (UPDRS-III), as measured at baseline and 6 weeks. The UPDRS-III is a clinical scale to assess severity of motor symptoms in Parkinson's disease. Each item is scored 0 (normal) to 4 (severe) with a score range from 0-132

    Time frame: baseline and 6 weeks

  5. Change in Activities-Specific Balance Confidence Scale

    The difference in Activities-Specific Balance Confidence (ABC) Scale, as measured at baseline and 6 weeks. The ABC Scale is a 16-item self-report scale that participants rate their confidence in performing daily activities. Score range from 0-100% with 0% meaning no confidence and 100% completely confident

    Time frame: baseline and 6 weeks

  6. Stride Velocity

    Stride velocity during straight walking averaged from daily monitoring, as measured at 6 weeks.

    Time frame: 6 weeks

  7. Stride Length

    Stride length during straight walking averaged from daily monitoring, as measured at 6 weeks.

    Time frame: 6 weeks

  8. Cadence

    The number of straight walking steps taken per minute averaged from daily monitoring, as measured at 6 weeks.

    Time frame: 6 weeks

  9. Double Support Time

    The amount of time both feet were on the ground together during straight walking averaged from daily monitoring, as measured at 6 weeks.

    Time frame: 6 weeks

  10. Angle of Foot at Heel Strike

    The angle between the foot and the ground at heel strike during straight walking averaged from daily monitoring, as measured at 6 weeks.

    Time frame: 6 weeks

  11. Variability of Angle of Foot at Heel Strike

    Coefficient of variation of the angle between the foot and the ground at heel strike during straight walking averaged from daily monitoring, as measured at 6 weeks.

    Time frame: 6 weeks

  12. Number of Turns Per Hour

    The average number of turns per hour measured during daily monitoring at 6 weeks.

    Time frame: 6 weeks

07

Results

Posted Nov 6, 2026

Participant flow

Participant flow — Overall Study
MilestoneNo Intervention Control GroupTURN-IT Group
Started2728
Pre-testing2725
Completed2522
Not completed26
Withdrew: Early termination14
Withdrew: Drop out02
Withdrew: Lost to follow-up10

Outcome measures

PrimaryVariability in Number of Steps to Complete a Turn

The coefficient of variation in the number of steps in a turn, averaged from daily monitoring, as measured at 6 weeks.

Time frame:
6 weeks
Reported as:
Mean · Coefficient of variation
Variability in Number of Steps to Complete a Turn
Coefficient of variationNo Intervention Control GroupTURN-IT Group
Variability in Number of Steps to Complete a Turn0.58 (0.57 to 0.59)0.57 (0.56 to 0.58)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · ANCOVA · p = 0.27 · Mean difference (final values): -0.34 · 95% CI -0.95 to 0.28Cohen's d (95% CI) calculated using σe
SecondaryChange in Falls Efficacy Scale International

The difference in the Falls Efficacy Scale, as measured at baseline and 6 weeks. The Falls Efficacy Scale is a 16 item self-administered questionnaire to assess fear of falling. Scores range 16-64 with higher score indicating more fear of falling.

Time frame:
baseline and 6 weeks
Reported as:
Mean · change in units on a scale
Change in Falls Efficacy Scale International
change in units on a scaleNo Intervention Control GroupTURN-IT Group
Change in Falls Efficacy Scale International0.56 (-2.3 to 3.42)-2.91 (-5.48 to -0.34)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · t-test, 2 sided · p = 0.07 (The study selected alpha was 0.05 and P-values were not adjusted for multiple comparisons.) · Mean difference (final values): -2.91 · 95% CI -5.48 to -0.34
SecondaryProspective Fall Incidence

Number of prospective falls recorded for 12 months starting from the end of intervention

Time frame:
52 weeks
Reported as:
Number · Falls
Prospective Fall Incidence
FallsNo Intervention Control GroupTURN-IT Group
Prospective Fall Incidence13.42 (12.01 to 15)14.95 (13.36 to 16.73)
SecondaryPatient Global Impression of Change

Question of participant's rating of mobility. Score range from 1-7 with 1-3 indicating improvement, 4 no change, and 5-7 worsening of mobility. Single score provided at the end of 6 week period.

Time frame:
6 weeks
Reported as:
Mean · score on a scale
Patient Global Impression of Change
score on a scaleNo Intervention Control GroupTURN-IT Group
Patient Global Impression of Change4.00 (4.0 to 4.5)3.00 (2.00 to 3.00)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · Wilcoxon (Mann-Whitney) · p = <0.001 (The study selected alpha was 0.05 and P-values were not adjusted for multiple comparisons.)
SecondaryNumber of Steps to Complete a Turn

The number of steps in a turning averaged from daily monitoring, as measured at 6 weeks.

Time frame:
6 weeks
Reported as:
Mean · Number of steps (log2)
Number of Steps to Complete a Turn
Number of steps (log2)No Intervention Control GroupTURN-IT Group
Number of Steps to Complete a Turn1.69 (1.67 to 1.72)1.71 (1.68 to 1.75)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · ANCOVA · p = 0.37 · Mean difference (final values): 0.28 · 95% CI -0.34 to 0.90Cohen's d (95% CI) calculated using σe
SecondaryTurn Peak Velocity

Peak velocity of turns averaged from daily monitoring, as measured at 6 weeks.

Time frame:
6 weeks
Reported as:
Mean · degrees per second
Turn Peak Velocity
degrees per secondNo Intervention Control GroupTURN-IT Group
Turn Peak Velocity86.41 (83.07 to 89.76)86.24 (82.81 to 89.66)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · ANCOVA · p = 0.94 · Mean difference (final values): -0.02 · 95% CI -0.63 to 0.59Cohen's d (95% CI) calculated using σe
SecondaryTurn Angle Amplitude

The peak size of turn angles averaged from daily monitoring, as measured at 6 weeks.

Time frame:
6 weeks
Reported as:
Mean · degrees per turn
Turn Angle Amplitude
degrees per turnNo Intervention Control GroupTURN-IT Group
Turn Angle Amplitude81.62 (80.34 to 82.9)82.13 (80.82 to 83.44)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · ANCOVA · p = 0.58 · Mean difference (final values): 0.17 · 95% CI -0.44 to 0.77Cohen's d (95% CI) calculated using σe
SecondaryTurn Duration

Time to complete turns averaged from daily monitoring, as measured at 6 weeks.

Time frame:
6 weeks
Reported as:
Mean · seconds
Turn Duration
secondsNo Intervention Control GroupTURN-IT Group
Turn Duration2.46 (2.42 to 2.5)2.50 (2.45 to 2.54)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · ANCOVA · p = 0.26 · Mean difference (final values): 0.35 · 95% CI -0.27 to 0.97Cohen's d (95% CI) calculated using σe
SecondaryVariability of Double-support Time

The coefficient of variation in time of double-support phase, as measured at 6 weeks.

Time frame:
6 weeks
Reported as:
Mean · Coefficient of variation
Variability of Double-support Time
Coefficient of variationNo Intervention Control GroupTURN-IT Group
Variability of Double-support Time0.22 (0.2 to 0.23)0.22 (0.21 to 0.23)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · ANCOVA · p = 0.636 · Mean difference (final values): 0.14 · 95% CI -0.46 to 0.74Cohen's d (95% CI) calculated using σe
SecondaryLateral Trunk Range

The range of motion in the trunk during walking, in the lateral direction, as measured at 6 weeks.

Time frame:
6 weeks
Reported as:
Mean · log-transformed degrees of motion
Lateral Trunk Range
log-transformed degrees of motionNo Intervention Control GroupTURN-IT Group
Lateral Trunk Range2.55 (2.45 to 2.64)2.53 (2.43 to 2.63)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · ANCOVA · p = 0.77 · Mean difference (final values): -0.09 · 95% CI -0.72 to 0.54Cohen's d (95% CI) calculated using σe
Other pre-specifiedChange in Mini-Balance Evaluation Systems Test

The change in mini-Balance Evaluation Systems Test, a clinical measure of four balance domains-anticipatory, reactive, sensory, and dynamic gait, as measured at baseline and 6 weeks. Scores range from 0-28 with higher scores indicating worse balance.

Time frame:
baseline and 6 weeks
Reported as:
Mean · change in units on a scale
Change in Mini-Balance Evaluation Systems Test
change in units on a scaleNo Intervention Control GroupTURN-IT Group
Change in Mini-Balance Evaluation Systems Test0.12 (-1.06 to 1.3)2.76 (1.54 to 3.98)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · t-test, 2 sided · Mean difference (net): 2.64 · 95% CI 1.00 to 4.29
Other pre-specifiedClinical Global Impression of Change

Question of clinician's rating of participant mobility. Score range from 1-7 with 1-3 indicating improvement, 4 no change, and 5-7 worsening of mobility. Single score provided at the end of 6 week period.

Time frame:
6 weeks
Reported as:
Median · score on a scale
Clinical Global Impression of Change
score on a scaleNo Intervention Control GroupTURN-IT Group
Clinical Global Impression of Change4.00 (3.00 to 4.00)4.00 (3.00 to 4.00)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · Wilcoxon (Mann-Whitney) · p = 0.5 (The study selected alpha was 0.05 and P-values were not adjusted for multiple comparisons.)
Other pre-specifiedChange in Parkinson's Disease Questionnaire-39

The difference in the Parkinson's disease questionnaire-39 (PDQ-39) - a 39 item self-report questionnaire to assess Parkinson's disease specific health related quality in eight domains of quality of life - as measured at baseline and 6 weeks. Each item scores from 0 (never) to 4 (always). Sub-scale scores and a Parkinson's Disease summary index (PDSI; sum of eight subsections/8) representing the global health-related quality of life will be calculated, with higher scores representing worse quality of life

Time frame:
baseline and 6 weeks
Reported as:
Mean · change in units on a scale
Change in Parkinson's Disease Questionnaire-39
change in units on a scaleNo Intervention Control GroupTURN-IT Group
Change in Parkinson's Disease Questionnaire-393.32 (-0.66 to 7.29)2.43 (-1.79 to 6.65)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · t-test, 2 sided · Mean difference (net): -0.89 · 95% CI -6.51 to 4.73
Other pre-specifiedChange in Unified Parkinson's Disease Rating Scale, Part III

Difference in the Unified Parkinson's Disease Rating Scale, Part III (UPDRS-III), as measured at baseline and 6 weeks. The UPDRS-III is a clinical scale to assess severity of motor symptoms in Parkinson's disease. Each item is scored 0 (normal) to 4 (severe) with a score range from 0-132

Time frame:
baseline and 6 weeks
Reported as:
Mean · change in units on a scale
Change in Unified Parkinson's Disease Rating Scale, Part III
change in units on a scaleNo Intervention Control GroupTURN-IT Group
Change in Unified Parkinson's Disease Rating Scale, Part III-1.36 (-4.72 to 2.0)-3.59 (-6.96 to -0.23)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · t-test, 2 sided · Mean difference (net): -2.23 · 95% CI -6.85 to 2.39
Other pre-specifiedChange in Activities-Specific Balance Confidence Scale

The difference in Activities-Specific Balance Confidence (ABC) Scale, as measured at baseline and 6 weeks. The ABC Scale is a 16-item self-report scale that participants rate their confidence in performing daily activities. Score range from 0-100% with 0% meaning no confidence and 100% completely confident

Time frame:
baseline and 6 weeks
Reported as:
Mean · change in units on a scale
Change in Activities-Specific Balance Confidence Scale
change in units on a scaleNo Intervention Control GroupTURN-IT Group
Change in Activities-Specific Balance Confidence Scale-0.99 (-5.56 to 3.57)6.83 (1.41 to 12.25)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · t-test, 2 sided · Mean difference (net): 7.82 · 95% CI 0.94 to 14.71
Other pre-specifiedStride Velocity

Stride velocity during straight walking averaged from daily monitoring, as measured at 6 weeks.

Time frame:
6 weeks
Reported as:
Mean · meters per second
Stride Velocity
meters per secondNo Intervention Control GroupTURN-IT Group
Stride Velocity0.89 (0.85 to 0.92)0.92 (0.88 to 0.96)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · ANCOVA · p = 0.21 · Mean difference (final values): 0.39 · 95% CI -0.24 to 1.01adjusted for centered baseline values
Other pre-specifiedStride Length

Stride length during straight walking averaged from daily monitoring, as measured at 6 weeks.

Time frame:
6 weeks
Reported as:
Mean · meters
Stride Length
metersNo Intervention Control GroupTURN-IT Group
Stride Length1.02 (0.99 to 1.03)1.04 (1.0 to 1.07)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · ANCOVA · p = 0.58 · Mean difference (final values): 0.18 · 95% CI -0.45 to 0.81Cohen's d (95% CI) calculated using σe
Other pre-specifiedCadence

The number of straight walking steps taken per minute averaged from daily monitoring, as measured at 6 weeks.

Time frame:
6 weeks
Reported as:
Mean · steps per minute
Cadence
steps per minuteNo Intervention Control GroupTURN-IT Group
Cadence51.45 (50.72 to 52.18)52.46 (51.7 to 53.22)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · ANCOVA · p = 0.061 · Mean difference (final values): 0.57 · 95% CI -0.04 to 1.18Cohen's d (95% CI) calculated using σe
Other pre-specifiedDouble Support Time

The amount of time both feet were on the ground together during straight walking averaged from daily monitoring, as measured at 6 weeks.

Time frame:
6 weeks
Reported as:
Mean · percent time spent in double support
Double Support Time
percent time spent in double supportNo Intervention Control GroupTURN-IT Group
Double Support Time25.46 (24.76 to 26.15)24.50 (23.77 to 25.23)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · ANCOVA · p = 0.066 · Mean difference (final values): -0.58 · 95% CI -1.20 to 0.05Cohen's d (95% CI) calculated using σe
Other pre-specifiedAngle of Foot at Heel Strike

The angle between the foot and the ground at heel strike during straight walking averaged from daily monitoring, as measured at 6 weeks.

Time frame:
6 weeks
Reported as:
Mean · degrees
Angle of Foot at Heel Strike
degreesNo Intervention Control GroupTURN-IT Group
Angle of Foot at Heel Strike-16.31 (-17.28 to -15.33)-16.26 (-17.28 to -15.24)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · ANCOVA · p = 0.95 · Mean difference (final values): 0.02 · 95% CI -0.61 to 0.65Cohen's d (95% CI) calculated using σe
Other pre-specifiedVariability of Angle of Foot at Heel Strike

Coefficient of variation of the angle between the foot and the ground at heel strike during straight walking averaged from daily monitoring, as measured at 6 weeks.

Time frame:
6 weeks
Reported as:
Mean · Coefficient of variation
Variability of Angle of Foot at Heel Strike
Coefficient of variationNo Intervention Control GroupTURN-IT Group
Variability of Angle of Foot at Heel Strike-0.44 (-0.48 to -0.40)-0.44 (-0.48 to -0.40)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · ANCOVA · p = 0.97 · Mean difference (final values): 0.01 · 95% CI -0.62 to 0.64Cohen's d (95% CI) calculated using σe
Other pre-specifiedNumber of Turns Per Hour

The average number of turns per hour measured during daily monitoring at 6 weeks.

Time frame:
6 weeks
Reported as:
Mean · turns completed per hour
Number of Turns Per Hour
turns completed per hourNo Intervention Control GroupTURN-IT Group
Number of Turns Per Hour21.94 (19.56 to 24.31)22.47 (20.05 to 24.9)
Statistical analysis
  • No Intervention Control Group vs TURN-IT Group · ANCOVA · p = 0.75 · Mean difference (final values): 0.10 · 95% CI -0.52 to 0.71Cohen's d (95% CI) calculated using σe

Adverse events

Collected over Roughly 8 weeks per participant. Adverse events were tracked from the time a participant signed an informed consent form to join the study to when they finished their post-intervention testing and daily life monitoring.. Non-serious events are listed at a 3% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
No Intervention Control Group0/27 (0%)0/27 (0%)0/27 (0%)
TURN-IT Group0/28 (0%)0/28 (0%)3/28 (10.7%)
Most frequent other events
Most frequent other events
EventNo Intervention Control GroupTURN-IT Group
COVIDRespiratory, thoracic and mediastinal disorders0/272/28
SciaticaNervous system disorders0/271/28

Baseline characteristics

The number of participants assessed at baseline differs from the number analyzed due to participant drop outs and loss to follow up.

Age, Continuous
Age, Continuous(years of age)TURN-IT GroupNo Intervention Control GroupTotal
Mean69.9 ± 5.8970.3 ± 6.6770.1 ± 6.23
Sex: Female, Male
Sex: Female, Male(Participants)TURN-IT GroupNo Intervention Control GroupTotal
Female131124
Male151631
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)TURN-IT GroupNo Intervention Control GroupTotal
Hispanic or Latino101
Not Hispanic or Latino252752
Unknown or Not Reported202
Race (NIH/OMB)
Race (NIH/OMB)(Participants)TURN-IT GroupNo Intervention Control GroupTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American000
White272754
More than one race000
Unknown or Not Reported101
Region of Enrollment
Region of Enrollment(Participants)TURN-IT GroupNo Intervention Control GroupTotal
United States282755
Experience Freezing of Gait
Experience Freezing of Gait(Participants)TURN-IT GroupNo Intervention Control GroupTotal
Yes161733
No121022
Body Mass Index
Body Mass Index(kg/m2)TURN-IT GroupNo Intervention Control GroupTotal
Mean25.0 ± 5.2824.8 ± 3.7224.9 ± 4.54
Years since Parkinson's diagnosis
Years since Parkinson's diagnosis(years)TURN-IT GroupNo Intervention Control GroupTotal
Mean9.68 ± 7.4811.1 ± 6.4210.4 ± 6.95

6 further baseline measures are reported on the registry.

08

Study locations

1 site
09

References and documents

Publications

  • King LA, Carlson-Kuhta P, Wilhelm JL, Lapidus JA, Dale ML, Talman LS, Barlow N, Mancini M, Horak FB. TURN-IT: a novel turning intervention program to improve quality of turning in daily life in people with Parkinson's disease. BMC Neurol. 2022 Nov 28;22(1):442. doi: 10.1186/s12883-022-02934-5. PubMed 36443737 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Upon reasonable request, we can share de-identified data related to study outcomes measures.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Data would be available 6 months after the end of data collection. Data will be stored in our laboratory data repository and so will be available indefinitely.

Access criteria: Data will not be stored on a public website, however researchers may contact us for access to the data. We will send data electronically via a secure server.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2021 to primary completion in Jun 2025, 45 months.

Results were first posted in Nov 2026, 1 year 4 months after primary completion.

Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's 45 months is above that.

Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

Completion moved once since we started tracking on Sep 25, 2026: Jun 2026 → Jul 2026, on Nov 6, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 18, 2021
First posted
May 21, 2021
StartActual
Sep 13, 2021
Primary completionActual
Jun 30, 2025
CompletionActual
Jul 1, 2026was Jun 2026
Results first posted
Nov 6, 2026
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 6, 2026
Results
Results posted
posted Nov 6, 2026
Study completion
Jun 1, 2026→Jul 1, 2026 (actual)
Nov 6, 2026
Eligibility
1 inclusion criterion edited; 1 exclusion criterion edited
What changed in the criteria
Inclusion criteria
  • Editedwilling and able to attend exercise intervention sessions at Oregon Health \& Science University (OHSU) campus, and also refrain from changes in anti-parkinson medications and exercise levels.
Exclusion criteria
  • EditedMontreal Cognitive Assessment (MoCA) ≤ 21 or inability to follow directions
Nov 6, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedChangeVariability in variability in numberNumber of stepsSteps to completeComplete a turnTurnTime frame: 6 weeks
Nov 6, 2026
Secondary outcomes
17 edited, 4 time frame changed, 3 removed, 4 description edited
What changed in the outcomes
  • EditedChange in prospective fall rateProspective Fall IncidenceTime frame: 52 weeks
  • EditedChange in patient global impressionPatient Global Impression of changeChangeTime frame: 6 weeks
  • EditedChange in numberNumber of stepsSteps to completeComplete a turnTurnTime frame: 6 weeks
  • EditedChange in turn peak velocityTurn Peak VelocityTime frame: 6 weeks
  • EditedChange in turn angle amplitudeTurn Angle AmplitudeTime frame: 6 weeks
  • EditedChange in turn durationTurn DurationTime frame: 6 weeks
  • EditedChange in variabilityVariability of doubleDouble-support timeTimeTime frame: 6 weeks
  • EditedChange in lateral trunk rangeLateral Trunk RangeTime frame: 6 weeks
  • RemovedChange in turn trunk jerkTime frame: 6 weeks
  • Time frameChange in Falls Efficacy Scale International6 weeks → baseline and 6 weeks
  • DescriptionChange in Falls Efficacy Scale International: how it is measured was reworded
  • Editedother outcomeChange in miniMini-Balance Evaluation Systems TestTime frame: 6 weeks → baseline and 6 weeks
  • Editedother outcomeChange in clinical global impressionClinical Global Impression of changeChangeTime frame: 6 weeks
  • Editedother outcomeChange in stride velocityStride VelocityTime frame: 6 weeks
  • Editedother outcomeChange in stride lengthStride LengthTime frame: 6 weeks
  • Editedother outcomeChange in cadenceCadenceTime frame: 6 weeks
  • Editedother outcomeChange in double support timeDouble Support TimeTime frame: 6 weeks
  • Editedother outcomeChange in angleAngle of footFoot at heel strikeHeel StrikeTime frame: 6 weeks
  • Editedother outcomeChange in variabilityVariability of angleAngle of footFoot at heel strikeHeel StrikeTime frame: 6 weeks
  • Editedother outcomeChange in numberNumber of turns per hourTurns Per HourTime frame: 6 weeks
  • Removedother outcomeChange in number of bouts of walking and steps per dayTime frame: 6 weeks
  • Removedother outcomeChange in duration of longest walking bout per dayTime frame: 6 weeks
  • Time frameother outcomeChange in Parkinson's Disease Questionnaire-396 weeks → baseline and 6 weeks
  • Time frameother outcomeChange in Unified Parkinson's Disease Rating Scale, Part III6 weeks → baseline and 6 weeks
  • Time frameother outcomeChange in Activities-Specific Balance Confidence Scale6 weeks → baseline and 6 weeks
  • Descriptionother outcomeChange in Activities-Specific Balance Confidence Scale: how it is measured was reworded
  • Descriptionother outcomeChange in Parkinson's Disease Questionnaire-39: how it is measured was reworded
  • Descriptionother outcomeChange in Unified Parkinson's Disease Rating Scale, Part III: how it is measured was reworded
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Active, not recruiting→Completed
    Results posted
    Study completion Jun 1, 2026→Jul 1, 2026 (now actual)
    Eligibility 1 inclusion criterion edited; 1 exclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • Editedwilling and able to attend exercise intervention sessions at Oregon Health \& Science University (OHSU) campus, and also refrain from changes in anti-parkinson medications and exercise levels.
    Exclusion criteria
    • EditedMontreal Cognitive Assessment (MoCA) ≤ 21 or inability to follow directions
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedChangeVariability in variability in numberNumber of stepsSteps to completeComplete a turnTurnTime frame: 6 weeks
    Secondary outcomes 17 edited, 4 time frame changed, 3 removed, 4 description edited
    What changed in the outcomes
    • EditedChange in prospective fall rateProspective Fall IncidenceTime frame: 52 weeks
    • EditedChange in patient global impressionPatient Global Impression of changeChangeTime frame: 6 weeks
    • EditedChange in numberNumber of stepsSteps to completeComplete a turnTurnTime frame: 6 weeks
    • EditedChange in turn peak velocityTurn Peak VelocityTime frame: 6 weeks
    • EditedChange in turn angle amplitudeTurn Angle AmplitudeTime frame: 6 weeks
    • EditedChange in turn durationTurn DurationTime frame: 6 weeks
    • EditedChange in variabilityVariability of doubleDouble-support timeTimeTime frame: 6 weeks
    • EditedChange in lateral trunk rangeLateral Trunk RangeTime frame: 6 weeks
    • RemovedChange in turn trunk jerkTime frame: 6 weeks
    • Time frameChange in Falls Efficacy Scale International6 weeks → baseline and 6 weeks
    • DescriptionChange in Falls Efficacy Scale International: how it is measured was reworded
    • Editedother outcomeChange in miniMini-Balance Evaluation Systems TestTime frame: 6 weeks → baseline and 6 weeks
    • Editedother outcomeChange in clinical global impressionClinical Global Impression of changeChangeTime frame: 6 weeks
    • Editedother outcomeChange in stride velocityStride VelocityTime frame: 6 weeks
    • Editedother outcomeChange in stride lengthStride LengthTime frame: 6 weeks
    • Editedother outcomeChange in cadenceCadenceTime frame: 6 weeks
    • Editedother outcomeChange in double support timeDouble Support TimeTime frame: 6 weeks
    • Editedother outcomeChange in angleAngle of footFoot at heel strikeHeel StrikeTime frame: 6 weeks
    • Editedother outcomeChange in variabilityVariability of angleAngle of footFoot at heel strikeHeel StrikeTime frame: 6 weeks
    • Editedother outcomeChange in numberNumber of turns per hourTurns Per HourTime frame: 6 weeks
    • Removedother outcomeChange in number of bouts of walking and steps per dayTime frame: 6 weeks
    • Removedother outcomeChange in duration of longest walking bout per dayTime frame: 6 weeks
    • Time frameother outcomeChange in Parkinson's Disease Questionnaire-396 weeks → baseline and 6 weeks
    • Time frameother outcomeChange in Unified Parkinson's Disease Rating Scale, Part III6 weeks → baseline and 6 weeks
    • Time frameother outcomeChange in Activities-Specific Balance Confidence Scale6 weeks → baseline and 6 weeks
    • Descriptionother outcomeChange in Activities-Specific Balance Confidence Scale: how it is measured was reworded
    • Descriptionother outcomeChange in Parkinson's Disease Questionnaire-39: how it is measured was reworded
    • Descriptionother outcomeChange in Unified Parkinson's Disease Rating Scale, Part III: how it is measured was reworded
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT04897256
Responsible party
Martina Mancini (Principal Investigator, Oregon Health and Science University) — Principal investigator
First posted
May 21, 2021
Start date
Sep 13, 2021
Primary completion
Jun 30, 2025
Completion
Jul 1, 2026
Results posted
Nov 6, 2026
Last update
Nov 6, 2026

Study contacts

Fay Horak, PhD, PT
principal investigator · Oregon Health and Science University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion